Oct 22, 2021 07:56 PM (GMT+8) · EqualOcean
Cailian, October 22 (Xinhua) -- according to the announcement of Hejia medical, the net profit in the first three quarters is expected to be RMB 0-8.0694 million, a year-on-year decrease of 90% - 100%. The decline in performance was mainly due to the decline in the share price of Weisi medical (688580) invested by the company's joint-stock company Shenzhen Yanghe Biomedical Industry Investment Co., Ltd., resulting in a significant decline in the investment income recognized by the company according to the equity method. The investment income recognized by the company in the first three quarters was about - 4.6 million yuan, and the investment income recognized in the same period last year was about 87 million yuan.